John S. (Pete) Lollar III, M.D.

Research Director, Hemostasis

Egleston
Education and Training Medical Degree: St. Louis University, St. Louis, MO, 1977
Residency: Internal Medicine, University of Iowa, Iowa City, IA, 1980-1982
Fellowship: Hematology, University of Iowa, Iowa City, IA, 1978-1980 Hematology, Mayo Clinic 1982-1984

Certifications

  • Internal Medicine
  • Subspecialty of Hematology
Professional Scientific Societies
  • American Society of Hematology
  • American Society for Biochemistry and Molecular Biology
  • American Chemical Society
  • The Protein Society
  • American Society for Clinical Investigation
  • International Society on Thrombosis and Haemostasis

Awards/Honors
  • American Heart Association, Established Investigator Award, 1987-92
  • American Heart Association National Peer Review Committee (Thrombosis), 2001- 2004
  • Holder/co-holder of 10 United States patents

Professional Interests
  • Development of improved treatment for patients with hemophilia
  • Blood coagulation
  • Cofounded a biotechnology company, Octagen, which licensed technology from Emory University to develop novel recombinant factor VIII molecules.

Privileges Egleston